Raj Manchanda
Hoofd Techniek/Wetenschap/O&O bij NEUMORA THERAPEUTICS, INC.
Profiel
Raj Manchanda is currently the Chief Technical Operations Officer at Neumora Therapeutics, Inc. Prior to this, he was the Chief Development Officer at Anokion US, Inc. from 2019 to 2023 and at Frequency Therapeutics, Inc. from 2016 to 2018.
Dr. Manchanda holds a doctorate degree from Yale University.
Actieve functies van Raj Manchanda
| Bedrijven | Functie | Begin |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2023 |
Eerdere bekende functies van Raj Manchanda
| Bedrijven | Functie | Einde |
|---|---|---|
| Anokion US, Inc. | Corporate Officer/Principal | 01-07-2023 |
| KORRO BIO, INC. | Corporate Officer/Principal | 01-10-2018 |
Opleiding van Raj Manchanda
| Yale University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Anokion US, Inc. | |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
